Mergers & Acquisitions

AtaiBeckley Inc.

AtaiBeckley Inc. (NASDAQ: ATAI) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, AtaiBeckley shareholders are expected to receive $6.75 per share in cash, plus up to $2.50 per share in the form of a Contingent Value Right entitling the holder to additional cash payments upon achievement of specified … Read more

First Hawaiian, Inc.

First Hawaiian, Inc. (NASDAQ: FHB) related to its merger with TriCo Bancshares. Upon closing of the proposed transaction, First Hawaiian shareholders are expected to own approximately 65% of the combined company.

TriCo Bancshares

TriCo Bancshares (NASDAQ: TCBK) related to its sale to First Hawaiian, Inc. Upon closing of the proposed transaction, TriCo shareholders are expected to own approximately 35% of the combined company.

NextCure, Inc.

NextCure, Inc. (NASDAQ: NXTC) related to its merger with Avere Therapeutics, Inc. Upon closing of the proposed transaction, NextCure shareholders are expected to own approximately 1.21% of the combined company.

Twin Vee PowerCats Co.

Twin Vee PowerCats Co. (NASDAQ: VEEE) related to its merger with USFM Corporation.

Pulmatrix, Inc.

Pulmatrix, Inc. (NASDAQ: PULM) related to its merger with Eos SENOLYTIX, Inc. Upon closing of the proposed transaction, Pulmatrix shareholders are expected to own approximately 6% of the combined company.

Solstice Advanced Materials, Inc.

Solstice Advanced Materials, Inc. (NASDAQ: SOLS) related to its merger with Element Solutions, Inc.

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected to receive $85.00 per share in cash.

Element Solutions, Inc.

Element Solutions, Inc. (NYSE: ESI) related to its sale to Solstice Advanced Materials, Inc. Under the terms of the proposed transaction, Element Solutions shareholders will receive $10.00 in cash and 0.500 shares of Solstice common stock for each Element Solutions share. Upon closing of the proposed transaction, Element Solutions shareholders are expected to own approximately 44% … Read more

ClearOne, Inc.

ClearOne, Inc. (NYSE: CLRO) related to its merger with Cortigent, Inc. Upon completion of the proposed transaction, ClearOne shareholders will own approximately 12.7% to 14.4% of the outstanding equity in the combined company.